The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects
Probucol (PB) is an hypolipidaemic drug with potential antidiabetic effects. We showed recently using in vitro studies that when PB was incorporated with stabilising lipophilic bile acids and microencapsulated using the polymer sodium alginate, the microcapsules showed good stability but poor and ir...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Springer
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/61659 |